Udoh, Michael
62  Ergebnisse:
Personensuche X
?
5

Cannabichromene is a cannabinoid CB2 receptor agonist:

Udoh, Michael ; Santiago, Marina ; Devenish, Steven..
British Journal of Pharmacology.  176 (2019)  23 - p. 4537-4547 , 2019
 
?
6

RESEARCHING AND FACILITATING AFRICAN AMERICAN GLOBAL VOLUNT..:

Mattis, Jacqueline S. ; Hope, Meredith O. ; Sutton, Ryan M...
The Review of Faith & International Affairs.  10 (2012)  1 - p. 29-36 , 2012
 
?
 
?
8

MEPIRAPIM-derived synthetic cannabinoids inhibit T-type cal..:

Harman, Thomas ; Udoh, Michael ; McElroy, Dan L...
Harman , T , Udoh , M , McElroy , D L , Anderson , L L , Kevin , R C , Banister , S D , Ametovski , A , Markham , J , Bladen , C , Doohan , P T , Greba , Q , Laprairie , R B , Snutch , T P , McGregor , I S , Howland , J G & Arnold , J C 2023 , ' MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy ' , Frontiers in Physiology , vol. 14 , 1086243 , pp. 1-15 . https://doi.org/10.3389/fphys.2023.1086243.  , 2023
 
?
9

The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibi..:

Udoh, Michael ; Bladen, Chris ; Heblinski, Marika...
Udoh , M , Bladen , C , Heblinski , M , Luo , J L , Janve , V S , Anderson , L L , McGregor , I S & Arnold , J C 2022 , ' The anticonvulsant phytocannabinoids CBGVA and CBDVA inhibit recombinant T-type channels ' , Frontiers in Pharmacology , vol. 13 , 1048259 , pp. 1-10 . https://doi.org/10.3389/fphar.2022.1048259.  , 2022
 
?
 
?
 
?
13

Cannabichromene is a Cannabinoid CB 2 receptor agonist:

Udoh, Michael ; Santiago, Marina ; Devenish, Steven..
Udoh , M , Santiago , M , Devenish , S , McGregor , I & Connor , M 2019 , ' Cannabichromene is a Cannabinoid CB 2 receptor agonist ' , British Journal of Pharmacology , vol. 176 , no. 23 , pp. 4537-4547 . https://doi.org/10.1111/bph.14815.  , 2019
 
?
15

MEPIRAPIM-derived synthetic cannabinoids inhibit T-type cal..:

Thomas Harman ; Michael Udoh ; Dan L. McElroy...
https://www.frontiersin.org/articles/10.3389/fphys.2023.1086243/full.  , 2023
 
1-15